Certain veterinary medicinal products authorised for oral administration via routes other than medicated feed may be associated with risks to public and animal health and to the environment. Their inappropriate administration or dosing can lead to possible reduction of the effectiveness of the treatments, development of antimicrobial or antiparasitic resistance, unintended administration to non-target animals and risks for the target animals, environment and consumers.
Recital 2, Regulation (EU) 2024/1159
In forcesince 7 Feb 2024